Healix at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Healix brings 3 presentations to IDWeek 2026 in Washington, and exhibits at Booth 1243. Its program centres on outpatient anti-infective infusion and on immunoglobulin treatment for patients with weakened immune systems. One study reports fewer infections in people with primary immunodeficiency after they start high-titer immunoglobulin.
| Organization | IDWeek 2026 Attendance |
|---|---|
Healix Sugar Land, TX | |
Runs a network of 300+ outpatient infusion centers and an accredited pharmacy that supplies injectable and infused medicines. | Booth Exhibiting at Booth 1243 Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm Poster Thu Oct 22 12:15pm–1:30pm Five-Year Real-World Trends in Outpatient Anti-Infective Therapy Across U.S. Physician Office Infusion Centers Session Fri Oct 23 12:15pm–12:45pm Rapid-Fire Poster Session: Old Foes, New Strategies Antimicrobials, resistance and stewardship Poster Sat Oct 24 12:15pm–1:30pm Infection Rate Reduction in Primary Immunodeficiency Patients Following Initiation of High-Titer Immunoglobulin: A Real-World Analysis |
Instantly find 20 buyers from Healix
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction